Age has its benefits

There are a number of stocks I believe you can collect to benefit from the ageing population. Careful accumulation or dollar-cost averaging should be beneficial over the next decade or so.

Challenger (ASX: CGF): It dominates the retail annuity market with an established strong brand and is expanding its distribution channels both domestically and internationally. A little expensive. Be patient.

CSL (CSL): Global demand for blood and influenza-related products will continue to increase at rates well above GDP growth. CSL is one of three major players in the global blood-plasma-derived biotherapies space with a market share over 30%. Diversification into influenzarelated vaccines provides another earnings stream in a growth category. A financially robust company with strong management.

Greencross (GXL): Perhaps an outlier, Greencross is the leading integrated pet care company in Australia and New Zealand and the largest provider of pet services. Pets are great companions as we get older and are spoilt by empty nesters. Accumulate.

InvoCare (IVC): InvoCare is the mar- ket leader in funeral services. A strong market position and solid reputation support a narrow “moat”, or competitive advantage. The number of deaths is highly predictable, creating a reliable revenue stream. A premium valuation is justified given growing revenue and earnings. Accumulate nearer fair value.

Ramsay Health Care (RHC): Australia’s premier private hospital al operator with an envious track record. The “Ramsay Way” of look- ooking after patients, staff and share- areholders works. The ageing population will drive demand for the company’s services. Accumulate.ulate.